Navigation Links
PharmAthene Reports First Quarter 2009 Financial and Operational Results
Date:5/15/2009

ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the first quarter ended March 31, 2009.

For the first quarter of 2009, PharmAthene recognized revenues of $5.5 million compared to $5.8 million in the same period of 2008. Revenues for the most recent quarter consisted primarily of contract funding from the U.S. government for the development of Protexia(R), SparVax(TM) and RypVax(TM).

Research and development expenses were $5.7 million for the quarter ended March 31, 2009 compared to $5.9 million in the same period last year. For both quarterly periods these expenses resulted from research and development activities related to programs for Valortim(R) and Protexia(R), and for the first quarter of 2009 also reflect activities related to the SparVax(TM), RypVax(TM) and our third generation rPA anthrax vaccine programs, which we acquired in the second quarter of 2008.

General and administrative expenses for the Company were $5.1 million for the quarter ended March 31, 2009 compared to $4.4 million in the same period in 2008. These amounts include non-cash stock compensation expense of $0.7 million and $0.5 million for the three months ended March 31, 2009 and 2008, respectively. General and administrative expenses increased $0.7 million in the first quarter of 2009 primarily due to increased consulting and legal services associated with compliance and operating as a publicly traded entity, costs related to preparing and submitting various bids and proposal, litigation efforts, and increased employee costs resulting primarily from the additional headcount through the Avecia acquisition. These increases were
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/12/2013)... HOUSTON , Dec. 12, 2013 ... Orthopedics & Sports Medicine on the campus ... findings of an innovative research study examining the ... the endurance and exercise efficiency of male and ... The study, directed by ...
(Date:12/12/2013)... , December 12, 2013 ... U.K.-Sino collaboration to drive localized solutions for improved ... Elsevier , a world-leading provider of scientific, technical ... part of the Reed Elsevier group, announced today ... medication decision support solution, known as Clinical Medication ...
(Date:12/12/2013)... 12, 2013  Research and Markets ( ... the "Global Next Generation Sequencing (NGS) ... offering. http://photos.prnewswire.com/prnh/20130307/600769  The NGS ... 2012, which accounted for the largest market ... platforms include Life Technologies (U.S.), 454 Roche ...
(Date:12/12/2013)... Saratoga Springs, NY (PRWEB) December 12, 2013 ... the 2013 Best of Saratoga Springs Award in the ... , Each year, the Saratoga Springs Award Program identifies ... in their local community and business category. These are ... business through service to their customers and our community. ...
Breaking Biology Technology:The Houston Methodist Human Performance Lab Launches Innovative Study on Triathletes, Investigating the Effects of Aging and Training Variables on Triathlon Performance 2The Houston Methodist Human Performance Lab Launches Innovative Study on Triathletes, Investigating the Effects of Aging and Training Variables on Triathlon Performance 3Elsevier Delivers Unified Medication Management Platform in China 2Elsevier Delivers Unified Medication Management Platform in China 3Global Next Generation Sequencing (NGS) Market Report 2013-2017 2Global Next Generation Sequencing (NGS) Market Report 2013-2017 3Criterium Inc Receives Award for Business Excellence in Medical Research for 2013 2
... path to cure diabetes, MINNEAPOLIS, June 16 ... to expedite the widespread availability of,islet tissue for ... its,Board of Directors: Steven D. Murphy and Timothy ... Steven D. Murphy is chief executive officer ...
... Corporation today announced,the appointment of Jim Meade, ... In addition to contributing to the strategic ... responsible for managing the development of,Lentigen,s partnerships, ... negotiations, and other key aspects of,corporate development., ...
... Cancer ... Therapy Product, PITTSBURGH, June ... Blum as the company,s,new Chief Executive Officer. With extensive experience in ... experience with,start-ups and Fortune 500 organizations, Ms. Blum brings 27 years ...
Cached Biology Technology:Spring Point Project Names New Members to Board of Directors 2Lentigen Appoints Jim Meade as Vice President of Corporate Development 2Applied Computational Technologies Appoints a New CEO 2
(Date:12/13/2013)... Texas Health Science Center at Houston (UTHealth) Barry ... been elected fellows into the American Association for the ... society and publisher of the journal Science . ... public health and his contributions to clinical trials especially ... into mechanisms underlying Alzheimer,s disease and other conditions. , ...
(Date:12/13/2013)... change are putting coral reefs in jeopardy, but a ... that very similar looking coral species differ in how ... unrecognized species diversity was hiding some corals, ability to ... of biology at Penn State University. A scientific paper ... print edition of the Proceedings of the Royal ...
(Date:12/13/2013)... A University of Colorado Boulder research center ... Corp.,s commercial Cygnus spacecraft to the International ... biomedical antibiotic experiment and an educational K-12 ... BioServe Space Technologies, a NASA-funded center in ... biomedical experiment to test the effectiveness of ...
Breaking Biology News(10 mins):UTHealth faculty members elected to prestigious scientific association 2Marine biologists unmask species diversity in coral reefs 2Marine biologists unmask species diversity in coral reefs 3CU-Boulder to fly antibiotic experiment, education project on ants to space station 2CU-Boulder to fly antibiotic experiment, education project on ants to space station 3
... pairing an experimental targeted therapy with a common ... lung cancer, researchers at UCLA's Jonsson Cancer Center ... the anti-inflammatory drug Celebrex increased response rates in ... Karen Reckamp, an assistant professor of hematology/oncology and ...
... of G&D, Dr. Marie-Louise Hammarskjold (UVA) and colleagues lend ... 1 tumor suppressor. The Wilms' Tumor 1 (WT1) protein ... with known roles in kidney and urogenital formation as ... and colleagues reveal that WT1 works not only at ...
... A new McGill University study that used thermal imaging technology for ... the conventional wisdom that women become aroused more slowly than men ... , "Comparing sexual arousal between men and women, we see ... takes healthy young men and women to reach peak arousal," said ...
Cached Biology News:Combination therapy shows promising results in patients with advanced lung cancer 2Combination therapy shows promising results in patients with advanced lung cancer 3Thermal imaging shatters arousal gender gap myth 2
... LIBS-ELITE houses Ocean Optics LIBS2000+ Spectrometers (sold ... Platform (UP) Ablation Chamber to offer numerous ... The systems features include a high-power 1064 ... functions, precise X-Y sample positioning, laser spot ...
... Systems offer an optional X-Ray Imaging ... to conveniently capture and precisely co-register ... whole animals with molecular based imaging ... signals that are generated by optical ...
... Cleanroom-grade vinyl curtains or parting ... steel support frame to form ... that meets cleanliness to Class ... filter/fan units, lights, and ionizers ...
... The first high-density serum biomarker chip to ... proteins. An antibody chip containing 120 human ... that enables biomarker discovery scientists to study ... benefits of therapy and the likelihood of ...
Biology Products: